Risk Communication for Nanobiotechnology: To Whom, about What, and Why?

Journal of Law, Medicine and Ethics 37 (4):759-769 (2009)
  Copy   BIBTEX

Abstract

Regulatory oversight and public communication are intimately intertwined. Oversight failures, both actual and perceived, quickly galvanize attention from both the media and the public, as has occasionally happened in all of the historical cases with which this symposium is concerned — gene therapy, workplace chemicals, drugs and devices, and genetically modified organisms, especially those used as foods. Some developments, such as GMOs, seem to have more cultural significance or “cultural resonance” than others and are especially likely to garner public attention. Developments in nanotechnology, on the other hand, do not seem to have captured as much popular attention. However, the accelerating convergence between nanotechnology as material science and biotechnology, health, and medicine could easily change this situation.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 94,698

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Analytics

Added to PP
2016-02-04

Downloads
15 (#972,690)

6 months
3 (#1,253,878)

Historical graph of downloads
How can I increase my downloads?